Cargando…

494. Fitness Cost of mcr-1-Mediated Colistin Resistance in Carbapenemase-Producing Klebsiella pneumoniae

BACKGROUND: The emergence of mobile colistin resistance gene mcr-1, a plasmid-borne polymyxin resistance mechanism, in carbapenem-resistant Klebsiella pneumoniae is an alarming concern. However, previous studies showed that the acquisition of mcr-1 was associated with a significant biological fitnes...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Yi-Tsung, Cheng, Yi-Hsiang, Chou, Sheng-Hua, Huang, Ying-Chi, Chen, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810815/
http://dx.doi.org/10.1093/ofid/ofz360.563
_version_ 1783462332835299328
author Lin, Yi-Tsung
Cheng, Yi-Hsiang
Chou, Sheng-Hua
Huang, Ying-Chi
Chen, Liang
author_facet Lin, Yi-Tsung
Cheng, Yi-Hsiang
Chou, Sheng-Hua
Huang, Ying-Chi
Chen, Liang
author_sort Lin, Yi-Tsung
collection PubMed
description BACKGROUND: The emergence of mobile colistin resistance gene mcr-1, a plasmid-borne polymyxin resistance mechanism, in carbapenem-resistant Klebsiella pneumoniae is an alarming concern. However, previous studies showed that the acquisition of mcr-1 was associated with a significant biological fitness cost in K. pneumoniae. We aimed to study the impact of mcr-1 on the biological fitness in clinical carbapenemase-producing K. pneumoniae strains. METHODS: Clinical carbapenemase-producing K. pneumoniae strains were collected consecutively at the Taipei Veterans General Hospital between November 2017 and December 2018. The strain positive for mcr-1 was subjected to whole-genome sequencing to delineate its genomic features. Escherichia coli J53 strain was used as the recipient strain in plasmid conjugation assay and the transconjugants were selected with sodium azide and colistin. Plasmid stability was tested by serial passaging in antibiotic-free LB broth for 28 days. The growth rate was compared between the parental mcr-1-bearing strain and the plasmid-cured strain. RESULTS: One ST11 strain isolated from a fatal case with bacteremia (KP2509) was found to harbor bla(KPC-2), bla(OXA-48), and mcr-1. This strain was resistant to colistin (MIC=8 mg/L) and imipenem (MIC≥16 mg/L). Whole-genome sequencing of KP2509 showed that mcr-1, bla(KPC-2) and bla(OXA-48) were located on an IncHI-FIB type plasmid of 319 Kb, an IncFII type plasmid of 96 Kb, and an IncL type plasmid of 64 Kb, respectively. Conjugation efficiency of mcr-1-bearing plasmid was 2.24 × 10(–4), and the colistin MIC of E. coli J53 transconjugant increased from 0.5 to 8 mg/L. The mcr-1-bearing plasmid in KP2509 showed high plasmid stability, and only ~1% were lost after 27-day passages. The resulting plasmid-cured strain (PC-KP2509) was susceptible to colistin (MIC=0.5 mg/L) and had a similar growth rate to that of parental mcr-1-bearing strain KP2509. CONCLUSION: We identified an ST11 K. pneumoniae strain carrying bla(KPC-2), bla(OXA-48), and mcr-1 genes causing a fatal bacteremia. The large mcr-1-bearing plasmid confers a moderate level of colistin resistance but without significant biological fitness cost in carbapenemase-producing K. pneumoniae, which could result in a serious threat clinically. DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6810815
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-68108152019-10-28 494. Fitness Cost of mcr-1-Mediated Colistin Resistance in Carbapenemase-Producing Klebsiella pneumoniae Lin, Yi-Tsung Cheng, Yi-Hsiang Chou, Sheng-Hua Huang, Ying-Chi Chen, Liang Open Forum Infect Dis Abstracts BACKGROUND: The emergence of mobile colistin resistance gene mcr-1, a plasmid-borne polymyxin resistance mechanism, in carbapenem-resistant Klebsiella pneumoniae is an alarming concern. However, previous studies showed that the acquisition of mcr-1 was associated with a significant biological fitness cost in K. pneumoniae. We aimed to study the impact of mcr-1 on the biological fitness in clinical carbapenemase-producing K. pneumoniae strains. METHODS: Clinical carbapenemase-producing K. pneumoniae strains were collected consecutively at the Taipei Veterans General Hospital between November 2017 and December 2018. The strain positive for mcr-1 was subjected to whole-genome sequencing to delineate its genomic features. Escherichia coli J53 strain was used as the recipient strain in plasmid conjugation assay and the transconjugants were selected with sodium azide and colistin. Plasmid stability was tested by serial passaging in antibiotic-free LB broth for 28 days. The growth rate was compared between the parental mcr-1-bearing strain and the plasmid-cured strain. RESULTS: One ST11 strain isolated from a fatal case with bacteremia (KP2509) was found to harbor bla(KPC-2), bla(OXA-48), and mcr-1. This strain was resistant to colistin (MIC=8 mg/L) and imipenem (MIC≥16 mg/L). Whole-genome sequencing of KP2509 showed that mcr-1, bla(KPC-2) and bla(OXA-48) were located on an IncHI-FIB type plasmid of 319 Kb, an IncFII type plasmid of 96 Kb, and an IncL type plasmid of 64 Kb, respectively. Conjugation efficiency of mcr-1-bearing plasmid was 2.24 × 10(–4), and the colistin MIC of E. coli J53 transconjugant increased from 0.5 to 8 mg/L. The mcr-1-bearing plasmid in KP2509 showed high plasmid stability, and only ~1% were lost after 27-day passages. The resulting plasmid-cured strain (PC-KP2509) was susceptible to colistin (MIC=0.5 mg/L) and had a similar growth rate to that of parental mcr-1-bearing strain KP2509. CONCLUSION: We identified an ST11 K. pneumoniae strain carrying bla(KPC-2), bla(OXA-48), and mcr-1 genes causing a fatal bacteremia. The large mcr-1-bearing plasmid confers a moderate level of colistin resistance but without significant biological fitness cost in carbapenemase-producing K. pneumoniae, which could result in a serious threat clinically. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2019-10-23 /pmc/articles/PMC6810815/ http://dx.doi.org/10.1093/ofid/ofz360.563 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Lin, Yi-Tsung
Cheng, Yi-Hsiang
Chou, Sheng-Hua
Huang, Ying-Chi
Chen, Liang
494. Fitness Cost of mcr-1-Mediated Colistin Resistance in Carbapenemase-Producing Klebsiella pneumoniae
title 494. Fitness Cost of mcr-1-Mediated Colistin Resistance in Carbapenemase-Producing Klebsiella pneumoniae
title_full 494. Fitness Cost of mcr-1-Mediated Colistin Resistance in Carbapenemase-Producing Klebsiella pneumoniae
title_fullStr 494. Fitness Cost of mcr-1-Mediated Colistin Resistance in Carbapenemase-Producing Klebsiella pneumoniae
title_full_unstemmed 494. Fitness Cost of mcr-1-Mediated Colistin Resistance in Carbapenemase-Producing Klebsiella pneumoniae
title_short 494. Fitness Cost of mcr-1-Mediated Colistin Resistance in Carbapenemase-Producing Klebsiella pneumoniae
title_sort 494. fitness cost of mcr-1-mediated colistin resistance in carbapenemase-producing klebsiella pneumoniae
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810815/
http://dx.doi.org/10.1093/ofid/ofz360.563
work_keys_str_mv AT linyitsung 494fitnesscostofmcr1mediatedcolistinresistanceincarbapenemaseproducingklebsiellapneumoniae
AT chengyihsiang 494fitnesscostofmcr1mediatedcolistinresistanceincarbapenemaseproducingklebsiellapneumoniae
AT choushenghua 494fitnesscostofmcr1mediatedcolistinresistanceincarbapenemaseproducingklebsiellapneumoniae
AT huangyingchi 494fitnesscostofmcr1mediatedcolistinresistanceincarbapenemaseproducingklebsiellapneumoniae
AT chenliang 494fitnesscostofmcr1mediatedcolistinresistanceincarbapenemaseproducingklebsiellapneumoniae